Serotonin: A mediator of the brain-gut connection

American Journal of Gastroenterology

Volumn 95, Issue 10, 2000, Pages 2698-2709

  Kim, Doe Young ^a   Camilleri, Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CISAPRIDE; CISPLATIN; DAZOPRIDE; DOXEPIN; FLUOXETINE; GRANISETRON; IMIPRAMINE; ONDANSETRON; PAROXETINE; PRUCALOPRIDE; R 108512; RENZAPRIDE; RO 93877; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SERTRALINE; SUMATRIPTAN; TEGASEROD; TROPISETRON; ZACOPRIDE;

BRAIN; CARCINOID; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; ELECTROLYTE TRANSPORT; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; IRRITABLE COLON; MOTOR PERFORMANCE; NEUROPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SECRETION; SENSORY SYSTEM; SEROTONIN METABOLISM; SEROTONIN RELEASE; SEROTONIN UPTAKE; VOMITING; ANIMAL; DIGESTIVE SYSTEM; HUMAN; INNERVATION; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; DIGESTIVE SYSTEM; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0034297908     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2000.03177.x     Document Type: Review

References (138)

1. Biochemistry of serotonin
2. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastrointestinal tract in the rat
3. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract
4. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: Their visualization and reactions to drug treatment
5. Synthesis of serotonin by neurons of the myenteric plexus in situ and in organotypic tissue culture
6. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: Their projections in the guinea pig small intestine
7. Serotonin accumulation in the guinea pig's myenteric plexus: Ion dependence, structure activity relationship and the effect of drugs
8. Release of endogenous 5-hydroxytryptamine from resting and stimulated enteric neurons
9. Synthesis and uptake of 5-hydroxytryptamine by the myenteric plexus of the small intestine of the guinea pig
10. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts
11. Transmitter neurochemistry of enteric neurons
12. Origin and metabolism of serotonin
13. Guinea pig 5-HT transporter: Cloning, expression, distribution, and function in intestinal sensory reception
14. Uptake and release of 5-hydroxytryptaminergic neurones: Effects of fluoxetine (Lilly 110140) and chlorimipramine
15. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract
16. Differences between males and females in rates of serotonin synthesis in human brain
17. Human brain serotonin synthesis capacity measured in vivo with α-[C-11] methly-L-tryptophan
18. Interaction of 5-hydroxytryptamine with autonomic and sensory neurons
19. Review article: Roles played by 5-hydroxytryptamine in the physiology of the bowel
20. Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex
21. The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis, the local production of 5-hydroxytryptamine and its release in relation to intraluminal pressure and propulsive activity
22. An investigation of the peristaltic reflex in relation to anatomical observations
23. The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs
24. The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa
25. Serotonin: Synthesis and release from the myenteric plexus of the mouse intestine
26. Serotonergic activation of tonic-type enteric neurons in guinea pig small bowel
27. Specific antagonism of enteric neural serotonin receptors by dipeptides of 5-hydroxytryptophan: Evidence that serotonin is a mediator of slow synaptic excitation in the myenteric plexus
28. Physiological responses of guinea-pig myenteric neurons secondary to the release of endogenous serotonin by tryptamine
29. Analysis of the role of 5-HT in the enteric nervous system using anti-idiotypic antibodies to 5-HT receptors
30. Synaptic activation and properties of 5-hydroxytryptamine(3) receptors in myenteric neurons of guinea pig intestine
31. Serotonin. Its role and receptors in enteric neurotransmission
32. 5-Hydroxytryptamine and enteric neurons
33. The 5-HT(1P) receptor
34. 5-Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach
35. The influence of bulbospinal monoaminergic pathways on sympathetic nerve activity
36. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
37. Effect of serotonin treatment on intestinal transport in the rabbit
38. A 5-HT receptor mediates serotonin-induced electrolyte transport in rat left colon
39. 5-Hydroxytryptamine and cholera secretion: A histochemical and physiological study
40. 5-Hydroxytryptamine, enterotoxins, and intestinal fluid secretion
41. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin
42. Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion
43. The effect of a serotonin antagonist (UML 491) in carcinoid disease
44. Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial
45. Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist
46. NIH conference: Serotonin now: Clinical implications of inhibiting its synthesis with para-chlorophenylalanine
47. 4 receptors of the release of 5-hydroxytryptamine from the guinea pig small intestine
48. Two kinds of tryptamine receptors
49. 5-Hydroxytryptamine receptor 'families'
50. A review of central 5-HT receptors and their function
51. Neurotransmission and neurotransmitters
52. 5-Hydroxytryptamine: New receptors and novel drugs for gastrointestinal motor disorders
53. Is 5HT a mediator in the motor control of the feline pylorus?
54. Multiple 5-hydroxytryptamine receptors on feline ileum and ileocecal sphincter
55. 3 receptors are membrane ion channels
56. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine
57. 4 and nicotinic receptors in the peristaltic reflex of guinea pig distal colon
58. 4 receptor-mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum
59. 3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum
60. 3 mediation of human gastrocolonic response and colonic peristaltic reflex
61. Serotonergic mediation of postprandial colonic tone and phasic responses in man
62. Ascending colon response to feeding: Evidence for a 5-hydroxytryptamine-3 mechanism
63. A 5HT antagonists corrects the postprandial colonic hypertonic response in carcinoid diarrhea
64. Nutrient tasting and signaling mechanisms in the gut II. The intestine as a sensor organ: Neural, endocrine, and immune response
65. 4/5-HT(1P) receptors on sensory CGRP neurons
66. Visceral nociceptors: A new world order?
67. Basic and clinical aspects of visceral hyperalgesia
68. Mechanical allodynia: A role for sensitized nociceptive tract cells with convergent input from mechano-receptors and nociceptors?
69. The functional gastrointestinal disorders and their diagnosis: A coming of age
70. Psychological factors in the care of patients with gastrointestinal disorders
71. Functional gastrointestinal disease and the autonomic nervous system: A way ahead?
72. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: A pilot study
73. 3 antagonist, in patients with irritable bowel syndrome
74. Colonic transit in man is slowed by ondansetron. (GR38032F): A selective 5-hydroxytryptamine receptor (type 3) antagonist
75. Selective 5-hydroxytryptamine antagonism: A role in irritable bowel syndrome and functional dyspepsia?
76. 5-Hydroxytryptamine receptors in the mouse duodenum
77. 3 receptor mediated release of an inhibitory transmitter in guinea-pig isolated ileum
78. 3 receptor antagonist, slows colonic transit in healthy man
79. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications
80. Alosetron shows colonic transit in patients with irritable bowel syndrome (IBS)
81. 3 receptor antagonist
82. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
83. 3 receptor antagonists
84. 3 receptor antagonist
85. 3 receptor antagonist
86. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors
87. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors
88. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea
89. Ondansetron in carcinoid syndrome
90. Ondansetron in carcinoid syndrome
91. 3 antagonist, alosetron, in patients with carcinoid diarrhea
92. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome
93. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors
94. 4 receptors
95. Analysis of serotonic mechanisms underlying benzamide-induced prokinesis
96. 4 receptors?
97. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig
98. A non-classical 5-hydroxytryptamine receptor positively coupled with adenlyate cyclase in the central nervous system
99. BRL 24924: A potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in the colliculi neurons
100. 4) positively coupled to adenylate cyclase in neurons
101. 4 receptor
102. Benzimidazolone derivatives: A new class of 5-hydroxytryptamine receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum
103. 4 receptor activation
104. Drugs affecting serotonin receptors
105. The influence of cisapride on gastric tone and the perception of gastric distension
106. 4 receptors mediating relaxation of canine isolated rectum circular smooth muscle
107. Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers
108. 4 agonist, prucalopride, in healthy humans
109. Prucalopride accelerates small bowel and colonic transit in patients with chronic functional constipation (FC) or constipation-predominant irritable bowel syndrome (C-IBS)
110. Prucalopride improves bowel movement frequency and symptoms in patients with chronic constipation: Results of two double-blind, placebo-controlled trials
111. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
112. 4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (IBS)
113. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cis-platin-induced nausea and vomiting
114. 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis
115. 3 antagonist (GR38032F) on small intestinal transit and release of gastrointestinal peptides
116. 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome. A pilot study
117. Clinical studies with granisetron, a new 5-HT receptor antagonist, for the treatment of cancer chemotherapy-induced emesis
118. Does granisetron remain effective over multiple cycles?
119. Granisetron, a selective 5-HT antagonist, for the prevention of radiation-induced emesis during total body irradiation
120. Tropisetron. A review of the clinical experience
121. Effect of ICS 205-930 (a specific 5HT receptor antagonist) on gastric emptying of a solid meal in normal subjects
122. Review article: The therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome
123. Inward currents in neurons from newborn guinea pig intestine: Mediation by 5-hydroxytryptamine type 3 receptors
124. 3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: A segmental perfusion study
125. Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (D-IBS)
126. Irritable bowel syndrome: A technical review for practice guideline development
127. Role of visceral afferent mechanisms in functional bowel disorders
128. Symptom relief with amitriptyline in irritable bowel syndrome
129. Role of impaired gastric accommodation to a meal in functional dyspepsia
130. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia
131. Influence of buspirone-induced fundus relaxation on the perception of gastric distention in man
132. A placebo-controlled trial of buspirone, a fundus relaxing drug, in functional dyspepsia: Effects on symptoms and gastric sensory and motor function
133. Serotonin uptake and serotonin uptake inhibition
134. Biochemistry and physiology of serotonergic transmission
135. Accumulation of tritiated 5-hydroxytryptamine in brain slices
136. Cloning and expression of a functional serotonin transporter from rat brain
137. Cloning of a serotonin transporter affected by antidepressants
138. Tails of serotonin and norepinephrine transporters; deletions and chimeras retain function